Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Device Removal | 5 | 2023 | 656 | 1.040 |
Why?
|
Angiography | 3 | 2020 | 1639 | 0.760 |
Why?
|
Vena Cava Filters | 3 | 2021 | 252 | 0.690 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 8 | 2008 | 290 | 0.630 |
Why?
|
Pulmonary Artery | 3 | 2024 | 1912 | 0.590 |
Why?
|
Foreign Bodies | 1 | 2019 | 399 | 0.500 |
Why?
|
Yttrium Radioisotopes | 1 | 2015 | 93 | 0.500 |
Why?
|
Pulmonary Embolism | 5 | 2021 | 2376 | 0.490 |
Why?
|
Embolization, Therapeutic | 4 | 2024 | 1392 | 0.480 |
Why?
|
Male Urogenital Diseases | 1 | 2014 | 48 | 0.480 |
Why?
|
Aortic Aneurysm, Abdominal | 5 | 2023 | 1186 | 0.460 |
Why?
|
Magnetic Resonance Angiography | 4 | 2021 | 1442 | 0.460 |
Why?
|
Catheterization, Peripheral | 1 | 2016 | 345 | 0.440 |
Why?
|
Ultrasonography, Interventional | 2 | 2023 | 1486 | 0.410 |
Why?
|
Radiography, Interventional | 1 | 2019 | 1095 | 0.410 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2009 | 627 | 0.380 |
Why?
|
Liver Neoplasms | 5 | 2020 | 4253 | 0.350 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 2 | 2024 | 139 | 0.350 |
Why?
|
Pelvis | 1 | 2014 | 730 | 0.350 |
Why?
|
Peripheral Arterial Disease | 2 | 2019 | 1188 | 0.340 |
Why?
|
Arteriovenous Malformations | 2 | 2024 | 396 | 0.320 |
Why?
|
Societies, Medical | 10 | 2023 | 3743 | 0.310 |
Why?
|
Chromomycin A3 | 1 | 2007 | 3 | 0.310 |
Why?
|
Radiology | 4 | 2020 | 2100 | 0.310 |
Why?
|
Brachytherapy | 1 | 2015 | 1248 | 0.300 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2020 | 2214 | 0.290 |
Why?
|
Vascular Diseases | 2 | 2019 | 1161 | 0.290 |
Why?
|
Endovascular Procedures | 2 | 2019 | 1979 | 0.280 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2009 | 1114 | 0.270 |
Why?
|
Pulmonary Veins | 2 | 2024 | 761 | 0.270 |
Why?
|
Quality Indicators, Health Care | 1 | 2015 | 1831 | 0.240 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2212 | 0.240 |
Why?
|
Radiology, Interventional | 2 | 2020 | 460 | 0.240 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2007 | 692 | 0.230 |
Why?
|
Blood Vessel Prosthesis | 2 | 2021 | 933 | 0.230 |
Why?
|
Cytotoxins | 1 | 2004 | 153 | 0.230 |
Why?
|
Carcinoma, Renal Cell | 5 | 2011 | 3143 | 0.220 |
Why?
|
Image Enhancement | 1 | 2014 | 2921 | 0.220 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.220 |
Why?
|
Quality Improvement | 2 | 2015 | 3749 | 0.220 |
Why?
|
Vena Cava, Inferior | 2 | 2016 | 440 | 0.220 |
Why?
|
Tumor Suppressor Proteins | 4 | 2007 | 2849 | 0.210 |
Why?
|
Cell Hypoxia | 4 | 2007 | 675 | 0.200 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2004 | 209 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 987 | 0.200 |
Why?
|
Ecchymosis | 1 | 2021 | 32 | 0.200 |
Why?
|
Iodine | 1 | 2023 | 286 | 0.190 |
Why?
|
Aneurysm, Infected | 1 | 2021 | 85 | 0.190 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 206 | 0.190 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2023 | 197 | 0.190 |
Why?
|
Arteriovenous Fistula | 1 | 2024 | 315 | 0.180 |
Why?
|
Catheters | 1 | 2023 | 425 | 0.180 |
Why?
|
Needles | 1 | 2023 | 449 | 0.180 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2020 | 191 | 0.180 |
Why?
|
Kidney Neoplasms | 4 | 2011 | 4262 | 0.170 |
Why?
|
Diagnostic Imaging | 5 | 2023 | 3507 | 0.170 |
Why?
|
Venous Thrombosis | 2 | 2020 | 1239 | 0.170 |
Why?
|
Alloys | 1 | 2019 | 122 | 0.170 |
Why?
|
Microwaves | 1 | 2020 | 191 | 0.170 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2020 | 85 | 0.160 |
Why?
|
Vasculitis | 2 | 2021 | 519 | 0.160 |
Why?
|
Oxygen | 7 | 2007 | 4189 | 0.160 |
Why?
|
Polytetrafluoroethylene | 1 | 2019 | 233 | 0.160 |
Why?
|
Neoplasms | 5 | 2019 | 21683 | 0.160 |
Why?
|
Cell Death | 1 | 2004 | 1706 | 0.160 |
Why?
|
Hemophilia A | 1 | 2021 | 351 | 0.160 |
Why?
|
Evidence-Based Medicine | 8 | 2023 | 3610 | 0.150 |
Why?
|
Thiazoles | 3 | 2010 | 1483 | 0.150 |
Why?
|
Coated Materials, Biocompatible | 1 | 2019 | 319 | 0.150 |
Why?
|
Iliac Artery | 1 | 2018 | 364 | 0.140 |
Why?
|
Quality Control | 1 | 2019 | 841 | 0.140 |
Why?
|
Drug Delivery Systems | 2 | 2010 | 2219 | 0.140 |
Why?
|
Autophagy | 3 | 2010 | 1300 | 0.140 |
Why?
|
Waiting Lists | 1 | 2020 | 692 | 0.140 |
Why?
|
Radiology Department, Hospital | 1 | 2020 | 412 | 0.140 |
Why?
|
Drug Carriers | 1 | 2020 | 693 | 0.140 |
Why?
|
Portal Vein | 2 | 2015 | 437 | 0.130 |
Why?
|
Ileal Diseases | 1 | 2016 | 74 | 0.130 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2017 | 129 | 0.130 |
Why?
|
Energy Metabolism | 1 | 2007 | 2899 | 0.130 |
Why?
|
Uterine Artery Embolization | 1 | 2016 | 62 | 0.130 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2016 | 97 | 0.130 |
Why?
|
Humans | 61 | 2024 | 744343 | 0.130 |
Why?
|
Urinary Fistula | 1 | 2015 | 42 | 0.130 |
Why?
|
Intestinal Fistula | 1 | 2016 | 140 | 0.130 |
Why?
|
Workflow | 1 | 2020 | 847 | 0.130 |
Why?
|
Prosthesis-Related Infections | 1 | 2021 | 538 | 0.130 |
Why?
|
Vascular Fistula | 1 | 2015 | 50 | 0.130 |
Why?
|
Aortic Diseases | 1 | 2021 | 742 | 0.130 |
Why?
|
Uterine Diseases | 1 | 2016 | 135 | 0.130 |
Why?
|
Fluoroscopy | 1 | 2019 | 924 | 0.130 |
Why?
|
Peripheral Vascular Diseases | 1 | 2018 | 550 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2004 | 2942 | 0.120 |
Why?
|
Bacteremia | 1 | 2021 | 962 | 0.120 |
Why?
|
Hepatic Encephalopathy | 1 | 2015 | 139 | 0.120 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 96 | 0.120 |
Why?
|
Extremities | 1 | 2019 | 865 | 0.120 |
Why?
|
Docosahexaenoic Acids | 1 | 2020 | 875 | 0.120 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 933 | 0.120 |
Why?
|
Mitochondria | 1 | 2007 | 3520 | 0.120 |
Why?
|
Vascular Malformations | 1 | 2019 | 454 | 0.120 |
Why?
|
Practice Management, Medical | 1 | 2015 | 196 | 0.120 |
Why?
|
Arterial Occlusive Diseases | 1 | 2018 | 793 | 0.110 |
Why?
|
Sialoglycoproteins | 2 | 2005 | 318 | 0.110 |
Why?
|
Triage | 1 | 2020 | 976 | 0.110 |
Why?
|
Hypertension, Portal | 1 | 2015 | 220 | 0.110 |
Why?
|
Staphylococcus aureus | 1 | 2021 | 1451 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2018 | 921 | 0.110 |
Why?
|
Intestinal Obstruction | 1 | 2016 | 424 | 0.110 |
Why?
|
Transcription Factors | 4 | 2005 | 12208 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2021 | 1400 | 0.100 |
Why?
|
Prosthesis Implantation | 1 | 2016 | 642 | 0.100 |
Why?
|
Glucose Transporter Type 1 | 1 | 2011 | 192 | 0.100 |
Why?
|
Critical Pathways | 1 | 2015 | 476 | 0.100 |
Why?
|
United States | 13 | 2023 | 69872 | 0.090 |
Why?
|
Aorta | 1 | 2018 | 2061 | 0.090 |
Why?
|
Leiomyoma | 1 | 2016 | 730 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1158 | 0.090 |
Why?
|
Osteopontin | 3 | 2006 | 296 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1 | 2 | 2008 | 198 | 0.090 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2009 | 86 | 0.080 |
Why?
|
Luminescent Measurements | 2 | 2008 | 405 | 0.080 |
Why?
|
von Hippel-Lindau Disease | 1 | 2010 | 152 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1671 | 0.080 |
Why?
|
Stents | 2 | 2024 | 3280 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2019 | 1288 | 0.080 |
Why?
|
Pyridines | 3 | 2010 | 2825 | 0.080 |
Why?
|
Luciferases, Firefly | 1 | 2008 | 46 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2001 | 2948 | 0.080 |
Why?
|
Proline | 3 | 2008 | 458 | 0.080 |
Why?
|
Quinones | 2 | 1998 | 76 | 0.080 |
Why?
|
Treatment Outcome | 9 | 2024 | 63114 | 0.080 |
Why?
|
Cell Line, Tumor | 8 | 2020 | 16689 | 0.080 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9648 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2020 | 2758 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2016 | 1513 | 0.070 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 12959 | 0.070 |
Why?
|
Neovascularization, Pathologic | 2 | 2009 | 2635 | 0.070 |
Why?
|
Wounds and Injuries | 1 | 2019 | 2400 | 0.070 |
Why?
|
Contrast Media | 4 | 2023 | 5300 | 0.070 |
Why?
|
Tumor Cells, Cultured | 6 | 2004 | 6314 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2004 | 1861 | 0.070 |
Why?
|
Neoplasm Staging | 2 | 2018 | 11031 | 0.070 |
Why?
|
Antineoplastic Agents | 5 | 2011 | 13695 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2015 | 1390 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1668 | 0.060 |
Why?
|
Male | 22 | 2021 | 350118 | 0.060 |
Why?
|
Aniline Compounds | 1 | 2010 | 986 | 0.060 |
Why?
|
Phlebography | 2 | 2016 | 333 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 730 | 0.060 |
Why?
|
Female | 18 | 2024 | 380194 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 8949 | 0.060 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2004 | 38 | 0.060 |
Why?
|
Neoplasms, Experimental | 1 | 2009 | 1276 | 0.060 |
Why?
|
Polyurethanes | 1 | 2024 | 107 | 0.060 |
Why?
|
Immediate-Early Proteins | 1 | 2006 | 453 | 0.060 |
Why?
|
Genes, Reporter | 1 | 2007 | 1547 | 0.060 |
Why?
|
Electric Power Supplies | 1 | 2023 | 99 | 0.050 |
Why?
|
Genes, ras | 1 | 2005 | 690 | 0.050 |
Why?
|
Head and Neck Neoplasms | 3 | 2006 | 2734 | 0.050 |
Why?
|
Animals | 18 | 2023 | 168757 | 0.050 |
Why?
|
Adult | 9 | 2024 | 214055 | 0.050 |
Why?
|
Middle Aged | 13 | 2024 | 213383 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2024 | 77449 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Electronics | 1 | 2023 | 322 | 0.050 |
Why?
|
Thrombin Time | 1 | 2021 | 7 | 0.050 |
Why?
|
Blotting, Western | 2 | 2007 | 5179 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2008 | 8428 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2009 | 2513 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 6 | 2023 | 20129 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2006 | 4034 | 0.050 |
Why?
|
Infusions, Intra-Arterial | 1 | 2020 | 234 | 0.050 |
Why?
|
Genes, Fungal | 1 | 2002 | 455 | 0.050 |
Why?
|
Hydroxylation | 3 | 2005 | 141 | 0.050 |
Why?
|
Clinical Competence | 1 | 2015 | 4687 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57776 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11124 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2016 | 2110 | 0.040 |
Why?
|
Factor VIII | 1 | 2021 | 347 | 0.040 |
Why?
|
Apoptosis | 4 | 2011 | 9727 | 0.040 |
Why?
|
Enhancer Elements, Genetic | 1 | 2005 | 1341 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1676 | 0.040 |
Why?
|
Algorithms | 5 | 2023 | 13881 | 0.040 |
Why?
|
Cyclophilins | 1 | 1998 | 46 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2021 | 646 | 0.040 |
Why?
|
Arm | 1 | 2021 | 589 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2005 | 1692 | 0.040 |
Why?
|
Peptidylprolyl Isomerase | 1 | 1998 | 105 | 0.040 |
Why?
|
Drainage | 1 | 2023 | 1142 | 0.040 |
Why?
|
Models, Molecular | 2 | 2008 | 5456 | 0.040 |
Why?
|
Photons | 1 | 2021 | 588 | 0.040 |
Why?
|
Physical Examination | 1 | 2023 | 1237 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2020 | 640 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2004 | 5853 | 0.040 |
Why?
|
Recurrence | 3 | 2018 | 8340 | 0.040 |
Why?
|
Ultrasonography | 2 | 2023 | 5985 | 0.040 |
Why?
|
Palpation | 1 | 2017 | 167 | 0.040 |
Why?
|
Aged | 8 | 2019 | 163280 | 0.040 |
Why?
|
Edema | 1 | 2021 | 789 | 0.040 |
Why?
|
Mice | 12 | 2009 | 81183 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4456 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 1998 | 3798 | 0.040 |
Why?
|
Rectum | 1 | 2021 | 904 | 0.040 |
Why?
|
Enoxaparin | 1 | 2019 | 377 | 0.040 |
Why?
|
Sirolimus | 1 | 2004 | 1564 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2020 | 2327 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 610 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2021 | 525 | 0.030 |
Why?
|
Biopsy | 2 | 2020 | 6756 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4568 | 0.030 |
Why?
|
Protons | 1 | 2021 | 1127 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2007 | 7722 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 3920 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 1998 | 404 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2004 | 2382 | 0.030 |
Why?
|
Lactulose | 1 | 2015 | 33 | 0.030 |
Why?
|
Texas | 1 | 2016 | 392 | 0.030 |
Why?
|
Young Adult | 3 | 2019 | 56430 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.030 |
Why?
|
Hepatic Veins | 1 | 2015 | 112 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2023 | 2480 | 0.030 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 1998 | 434 | 0.030 |
Why?
|
Time Factors | 5 | 2019 | 40075 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2021 | 2879 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1997 | 563 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2021 | 1063 | 0.030 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 222 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2618 | 0.030 |
Why?
|
Angiography, Digital Subtraction | 1 | 2015 | 341 | 0.030 |
Why?
|
Heparin | 1 | 2021 | 1637 | 0.030 |
Why?
|
Trans-Activators | 1 | 2004 | 2924 | 0.030 |
Why?
|
Doxorubicin | 2 | 2017 | 2234 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4042 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1997 | 686 | 0.030 |
Why?
|
Trauma Centers | 1 | 2019 | 890 | 0.030 |
Why?
|
Swine | 1 | 2023 | 5917 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2010 | 3129 | 0.030 |
Why?
|
Mice, SCID | 2 | 2009 | 2716 | 0.030 |
Why?
|
Liver | 2 | 2020 | 7474 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1774 | 0.030 |
Why?
|
Research | 1 | 2002 | 1999 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2019 | 1462 | 0.030 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2021 | 1624 | 0.030 |
Why?
|
Vascular Patency | 1 | 2015 | 886 | 0.030 |
Why?
|
Dactinomycin | 2 | 2005 | 318 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2015 | 559 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6895 | 0.030 |
Why?
|
Graft Occlusion, Vascular | 1 | 2015 | 549 | 0.030 |
Why?
|
Necrosis | 1 | 2016 | 1643 | 0.030 |
Why?
|
Mice, Nude | 2 | 2008 | 3689 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2016 | 1206 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3582 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2016 | 576 | 0.020 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12354 | 0.020 |
Why?
|
Hysterectomy | 1 | 2016 | 927 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1928 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 7023 | 0.020 |
Why?
|
Mutation | 5 | 2008 | 29786 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2759 | 0.020 |
Why?
|
Nanoparticles | 1 | 2020 | 1905 | 0.020 |
Why?
|
Rats | 3 | 2020 | 24260 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 9274 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2250 | 0.020 |
Why?
|
Program Development | 1 | 2015 | 1316 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1998 | 2440 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6103 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2007 | 3557 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5078 | 0.020 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2009 | 154 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2006 | 5256 | 0.020 |
Why?
|
Luciferases, Renilla | 1 | 2007 | 22 | 0.020 |
Why?
|
Consensus | 1 | 2017 | 2959 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12245 | 0.020 |
Why?
|
Vacuoles | 1 | 2008 | 230 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2006 | 3870 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 459 | 0.020 |
Why?
|
Transfection | 2 | 2008 | 5892 | 0.020 |
Why?
|
Yeasts | 1 | 2008 | 285 | 0.020 |
Why?
|
Glycolysis | 1 | 2011 | 827 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13284 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9438 | 0.020 |
Why?
|
Genes, p53 | 2 | 2001 | 755 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2008 | 408 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2016 | 1475 | 0.020 |
Why?
|
Benzoquinones | 2 | 1998 | 201 | 0.020 |
Why?
|
Thymidine Kinase | 1 | 2007 | 290 | 0.020 |
Why?
|
Program Evaluation | 1 | 2015 | 2488 | 0.020 |
Why?
|
Golgi Apparatus | 1 | 2008 | 410 | 0.020 |
Why?
|
Risk Factors | 3 | 2020 | 72290 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 690 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2007 | 573 | 0.020 |
Why?
|
Connective Tissue Growth Factor | 1 | 2006 | 96 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2008 | 280 | 0.020 |
Why?
|
Pain | 1 | 2021 | 4986 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2016 | 1956 | 0.020 |
Why?
|
Lactams, Macrocyclic | 2 | 1998 | 320 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2018 | 15295 | 0.020 |
Why?
|
Reoperation | 1 | 2015 | 4201 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 399 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2009 | 2085 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2025 | 0.020 |
Why?
|
Lysosomes | 1 | 2010 | 893 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6538 | 0.020 |
Why?
|
Carrier Proteins | 1 | 1998 | 5021 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2007 | 853 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14722 | 0.020 |
Why?
|
Mixed Function Oxygenases | 1 | 2005 | 272 | 0.010 |
Why?
|
Response Elements | 1 | 2005 | 312 | 0.010 |
Why?
|
Antibody Specificity | 1 | 2006 | 1095 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2004 | 279 | 0.010 |
Why?
|
3T3 Cells | 1 | 2005 | 1101 | 0.010 |
Why?
|
Molecular Structure | 1 | 2008 | 1899 | 0.010 |
Why?
|
Anticoagulants | 1 | 2019 | 4599 | 0.010 |
Why?
|
RNA Stability | 1 | 2005 | 321 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2008 | 2557 | 0.010 |
Why?
|
Prognosis | 2 | 2018 | 29063 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2005 | 13033 | 0.010 |
Why?
|
Cell Line | 3 | 2005 | 15997 | 0.010 |
Why?
|
Cullin Proteins | 1 | 2004 | 180 | 0.010 |
Why?
|
Transcriptional Activation | 2 | 2001 | 1783 | 0.010 |
Why?
|
Amino Acids, Dicarboxylic | 1 | 2002 | 25 | 0.010 |
Why?
|
Microtubule-Associated Proteins | 1 | 2008 | 1086 | 0.010 |
Why?
|
Protein Transport | 1 | 2008 | 1988 | 0.010 |
Why?
|
Cobalt | 1 | 2002 | 158 | 0.010 |
Why?
|
Deferoxamine | 1 | 2002 | 151 | 0.010 |
Why?
|
Gene Silencing | 1 | 2008 | 1538 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 35421 | 0.010 |
Why?
|
Ligases | 1 | 2003 | 333 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2003 | 1581 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9146 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2007 | 3701 | 0.010 |
Why?
|
Chelating Agents | 1 | 2002 | 380 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 2004 | 634 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 4554 | 0.010 |
Why?
|
Databases as Topic | 1 | 2003 | 475 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 20947 | 0.010 |
Why?
|
NF-kappa B | 1 | 2009 | 2499 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 733 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2006 | 1275 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 85781 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3922 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3772 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1917 | 0.010 |
Why?
|
Glucose | 1 | 2011 | 4397 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1682 | 0.010 |
Why?
|
Ubiquitin | 1 | 2004 | 852 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2005 | 14557 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 2938 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2001 | 380 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2006 | 2924 | 0.010 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 112 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3846 | 0.010 |
Why?
|
Cell Survival | 1 | 2008 | 5882 | 0.010 |
Why?
|
Acetylation | 1 | 2001 | 1085 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1998 | 242 | 0.010 |
Why?
|
Intramolecular Oxidoreductases | 1 | 1998 | 109 | 0.010 |
Why?
|
Octoxynol | 1 | 1997 | 77 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2004 | 1119 | 0.010 |
Why?
|
Leupeptins | 1 | 1997 | 122 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6473 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1997 | 192 | 0.010 |
Why?
|
Cycloheximide | 1 | 1997 | 347 | 0.010 |
Why?
|
Gamma Rays | 1 | 1998 | 320 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1997 | 190 | 0.010 |
Why?
|
Detergents | 1 | 1997 | 230 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 1998 | 537 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2005 | 2503 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2004 | 2203 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2009 | 3479 | 0.010 |
Why?
|
Half-Life | 1 | 1997 | 661 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2005 | 12072 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2001 | 728 | 0.010 |
Why?
|
Protein Conformation | 1 | 2004 | 4011 | 0.010 |
Why?
|
Growth Substances | 1 | 1998 | 784 | 0.010 |
Why?
|
Acetylcysteine | 1 | 1997 | 272 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2001 | 789 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 53288 | 0.010 |
Why?
|
Ubiquitins | 1 | 1997 | 384 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3703 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3505 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2002 | 1783 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2005 | 3086 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40561 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2001 | 2715 | 0.010 |
Why?
|
Iron | 1 | 2002 | 1774 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2915 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 1998 | 742 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2009 | 19229 | 0.010 |
Why?
|
Homeostasis | 1 | 2004 | 3340 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3462 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10481 | 0.010 |
Why?
|
Cisplatin | 1 | 1998 | 1662 | 0.010 |
Why?
|
Lymphoma | 1 | 2001 | 1877 | 0.010 |
Why?
|
Binding Sites | 1 | 2001 | 6114 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2004 | 13815 | 0.010 |
Why?
|
Fibroblasts | 1 | 2002 | 4161 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2969 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 1997 | 1182 | 0.010 |
Why?
|
DNA Damage | 1 | 2001 | 2432 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 18111 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1997 | 1338 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2002 | 2752 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 15076 | 0.010 |
Why?
|
Protein Binding | 1 | 2002 | 9386 | 0.010 |
Why?
|
Phosphorylation | 1 | 2001 | 8436 | 0.010 |
Why?
|
Computational Biology | 1 | 2002 | 3521 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2007 | 19905 | 0.010 |
Why?
|
Internet | 1 | 2001 | 3064 | 0.010 |
Why?
|
Software | 1 | 2001 | 4443 | 0.000 |
Why?
|
Gene Expression | 1 | 1998 | 7799 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9583 | 0.000 |
Why?
|
Signal Transduction | 1 | 2001 | 23403 | 0.000 |
Why?
|